Sean Bohen - Net Worth and Insider Trading
Sean Bohen Net Worth
The estimated net worth of Sean Bohen is at least $2 Million dollars as of 2024-11-05. Sean Bohen is the PRESIDENT AND CEO of Olema Pharmaceuticals inc and owns about 144,925 shares of Olema Pharmaceuticals inc (OLMA) stock worth over $2 Million. Details can be seen in Sean Bohen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sean Bohen has not made any transactions after 2023-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sean Bohen
Sean Bohen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sean Bohen owns 1 companies in total, including Olema Pharmaceuticals inc (OLMA) .
Click here to see the complete history of Sean Bohen’s form 4 insider trades.
Insider Ownership Summary of Sean Bohen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals inc | 2023-11-22 | director & President and CEO |
Sean Bohen Latest Holdings Summary
Sean Bohen currently owns a total of 1 stock. Sean Bohen owns 144,925 shares of Olema Pharmaceuticals inc (OLMA) as of November 22, 2023, with a value of $2 Million.
Latest Holdings of Sean Bohen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals inc | 2023-11-22 | 144,925 | 11.91 | 1,725,332 |
Holding Weightings of Sean Bohen
Sean Bohen Form 4 Trading Tracker
According to the SEC Form 4 filings, Sean Bohen has made a total of 5 transactions in Olema Pharmaceuticals inc (OLMA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Olema Pharmaceuticals inc is the sale of 57,225 shares on November 22, 2023, which brought Sean Bohen around $824,040.
Insider Trading History of Sean Bohen
- 1
Sean Bohen Trading Performance
Sean Bohen Ownership Network
Ownership Network List of Sean Bohen
Ownership Network Relation of Sean Bohen
Sean Bohen Owned Company Details
What does Olema Pharmaceuticals inc do?
Who are the key executives at Olema Pharmaceuticals inc?
Sean Bohen is the director & President and CEO of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include 10 percent owner Paradigm Biocapital Advisors Lp , director & Chief Technology Officer Cyrus Harmon , and Chief Development Officer David C. Myles .
Olema Pharmaceuticals inc (OLMA) Insider Trades Summary
Over the past 18 months, Sean Bohen made 1 insider transaction in Olema Pharmaceuticals inc (OLMA) with a net sale of 57,225. Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 338,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 2,300,000 shares made by Paradigm Biocapital Advisors Lp .
In summary, during the past 3 months, insiders sold 0 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,048,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,245,932 shares were bought by its insiders, resulting in a net sale of 1,802,142 shares.
Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Olema Pharmaceuticals inc Insider Transactions
Sean Bohen Mailing Address
Above is the net worth, insider trading, and ownership report for Sean Bohen. You might contact Sean Bohen via mailing address: C/o Olema Pharmaceuticals, Inc., 512 2nd Street, 4th Floor, San Francisco Ca 94107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
